Tuberculosis vaccine shows promise as once-fatal disease evades treatment

Tuberculosis infected more than 8 million people in 2024 — surpassing COVID-19 and marking a record high since 1995 — as a new Johns Hopkins-developed vaccine emerges amid rising antibioticRead More